Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)

NCT05587374 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

490

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Nasopharyngeal Cancer

Interventions

DRUG: Cadonilimab
DRUG: Gemcitabine
DRUG: Cisplatin
RADIATION: Intensity-modulated radiotherapy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]